首页 > 最新文献

Central nervous system agents in medicinal chemistry最新文献

英文 中文
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice. 磷酸吡哆醛对氯丙嗪诱导的帕金森病小鼠治疗作用的评价。
Q3 Psychology Pub Date : 2020-01-01 DOI: 10.2174/1871524920666200120142508
Anthony T Olofinnade, Tolulope M Onaolapo, Samad Oladimeji, Adetunji M Fatoki, Covenant I Balogun, Adejoke Y Onaolapo, Olakunle J Onaolapo

Background: Parkinsonism is a neurodegenerative disorder with a heavy disease burden, despite the discovery and application of drugs. Current research is beginning to suggest the possible crucial roles of micronutrients such as pyridoxal phosphate in the prevention or management of neurodegenerative disorders.

Objective: We investigated the possible protective effects of supplemental pyridoxal phosphate in Chlorpromazine (CPZ)-induced Parkinsonism-like changes in mice.

Methods: Mice were assigned to eight groups of 30 mice each. Groups included Vehicle control (fed standard diet (SD), and administered intraperitoneal {ip} injection of saline and saline per orem), levodopa-carbidopa (LD) group (SD, saline ip and LD per orem), two groups fed pyridoxal phosphate-supplemented diet (at 100 and 200 mg/kg of feed), and administered saline both ip and orally, CPZ group (SD, CPZ ip and saline per orem), CPZ/LD group (SD, CPZ ip and LD per orem) and finally two groups fed pyridoxal phosphate -supplemented diet (at 100 and 200 mg/kg of feed) and administered CPZ ip plus saline per orem. Treatments were administered daily for a period of 21 days to allow for the induction of Parkinsonism features. Body weight and food intake were measured weekly while neurobehavioural and biochemical tests were assessed at the end of the experimental period.

Results: Pyridoxal phosphate supplementation was associated with a reduction in CPZ-induced suppression of open-field horizontal locomotion and rearing; and a significant increase in grooming activity. Administration of pyridoxal phosphate-supplemented diet was also associated with improvements in working-memory in CPZ-treated mice; and there was reduction in the index of anxiety and catalepsy score.

Conclusion: Pyridoxal phosphate supplementation was associated with significant benefits in CPZ-induced Parkinsonism-like changes in mice.

背景:帕金森病是一种神经退行性疾病,尽管有药物的发现和应用,但疾病负担很重。目前的研究开始表明,磷酸吡哆醛等微量营养素在预防或治疗神经退行性疾病方面可能起着关键作用。目的:探讨补充磷酸吡哆醛对氯丙嗪(CPZ)诱导的小鼠帕金森样病变可能的保护作用。方法:将小鼠分为8组,每组30只。各组分别为:载体对照组(饲喂标准饲料(SD),并腹腔注射生理盐水和每孔生理盐水)、左旋多巴-卡比多巴(LD)组(SD、生理盐水和每孔生理盐水)、两组分别饲喂磷酸吡哆醛添加饲料(饲料剂量分别为100和200 mg/kg),并同时给予生理盐水和口服,CPZ组(SD、CPZ ip和每孔生理盐水)、CPZ/LD组(SD、CPZ ip和每孔生理盐水)、CPZ/LD组(SD、最后两组分别饲喂磷酸吡哆醛添加饲粮(100和200 mg/kg饲料),每孔喂CPZ +生理盐水。在21天的时间里,每天进行治疗,以诱导帕金森病的特征。每周测量体重和食物摄入量,在实验结束时评估神经行为和生化测试。结果:磷酸吡哆醛的补充与cpz诱导的开阔地水平运动和饲养抑制的减少有关;梳理毛发的活动也显著增加。磷酸吡哆醛补充饮食也与cpz处理小鼠的工作记忆改善有关;焦虑指数和癫痫评分也有所下降。结论:补充磷酸吡哆醛对cpz诱导的小鼠帕金森样变化有显著的益处。
{"title":"An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice.","authors":"Anthony T Olofinnade,&nbsp;Tolulope M Onaolapo,&nbsp;Samad Oladimeji,&nbsp;Adetunji M Fatoki,&nbsp;Covenant I Balogun,&nbsp;Adejoke Y Onaolapo,&nbsp;Olakunle J Onaolapo","doi":"10.2174/1871524920666200120142508","DOIUrl":"https://doi.org/10.2174/1871524920666200120142508","url":null,"abstract":"<p><strong>Background: </strong>Parkinsonism is a neurodegenerative disorder with a heavy disease burden, despite the discovery and application of drugs. Current research is beginning to suggest the possible crucial roles of micronutrients such as pyridoxal phosphate in the prevention or management of neurodegenerative disorders.</p><p><strong>Objective: </strong>We investigated the possible protective effects of supplemental pyridoxal phosphate in Chlorpromazine (CPZ)-induced Parkinsonism-like changes in mice.</p><p><strong>Methods: </strong>Mice were assigned to eight groups of 30 mice each. Groups included Vehicle control (fed standard diet (SD), and administered intraperitoneal {ip} injection of saline and saline per orem), levodopa-carbidopa (LD) group (SD, saline ip and LD per orem), two groups fed pyridoxal phosphate-supplemented diet (at 100 and 200 mg/kg of feed), and administered saline both ip and orally, CPZ group (SD, CPZ ip and saline per orem), CPZ/LD group (SD, CPZ ip and LD per orem) and finally two groups fed pyridoxal phosphate -supplemented diet (at 100 and 200 mg/kg of feed) and administered CPZ ip plus saline per orem. Treatments were administered daily for a period of 21 days to allow for the induction of Parkinsonism features. Body weight and food intake were measured weekly while neurobehavioural and biochemical tests were assessed at the end of the experimental period.</p><p><strong>Results: </strong>Pyridoxal phosphate supplementation was associated with a reduction in CPZ-induced suppression of open-field horizontal locomotion and rearing; and a significant increase in grooming activity. Administration of pyridoxal phosphate-supplemented diet was also associated with improvements in working-memory in CPZ-treated mice; and there was reduction in the index of anxiety and catalepsy score.</p><p><strong>Conclusion: </strong>Pyridoxal phosphate supplementation was associated with significant benefits in CPZ-induced Parkinsonism-like changes in mice.</p>","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"20 1","pages":"13-25"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37582260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
β-1,3-glucan Attenuated Chronic Unpredictable Mild Stress-induced Cognitive Impairment in Rodents via Normalizing Corticosterone Levels. β-1,3-葡聚糖通过使皮质酮水平正常化来减轻啮齿动物慢性不可预测的轻度应激性认知障碍。
Q3 Psychology Pub Date : 2020-01-01 DOI: 10.2174/1871524920666200810142359
Saniya H Khan, Sheraz Khan, Narmeen Hashim, Inamullah Khan

Background: Chronic stress elevates the cortisol beyond normal levels, which affects cognition including learning & memory. This injurious effect is primarily mediated via over excitation of metabotropic glucocorticoid receptors (mGR).

Methods: The present study was aimed to appraise the neuroprotective effects of naturally occurring molecule β-1,3-glucan by interfering with stress-cortisol-mGR axis. Our data of virtual screening (in silico) exhibited the promising interactions of β-glucan with the mGR. Therefore, the study was extended to evaluate its efficacy (2.5, 5 and 10 mg/kg/ i.p) in an animal model of chronic unpredictable mild stress (CUMS, 28 days) induced memory impairment.

Results: Results of the current study revealed the β-glucan provided dose dependent protection against deleterious effects of stress on learning and memory associated parameters observed in Morris water maze (MWM) task. At higher tested doses, it has also significantly antagonized the stress induced weight loss and corticosterone elevation.

背景:慢性应激会使皮质醇升高到正常水平以上,从而影响包括学习和记忆在内的认知。这种有害作用主要通过代谢糖皮质激素受体(mGR)的过度兴奋介导。方法:本研究旨在通过干扰应激-皮质醇- mgr轴,评价天然分子β-1,3-葡聚糖的神经保护作用。我们的虚拟筛选数据(在硅)显示β-葡聚糖与mGR有希望的相互作用。因此,本研究扩展到评估其(2.5、5和10 mg/kg/ i.p)对慢性不可预测轻度应激(CUMS, 28天)诱导的记忆障碍动物模型的疗效。结果:在Morris水迷宫(MWM)实验中,β-葡聚糖对应激对大鼠学习记忆相关参数的影响具有剂量依赖性。在更高的测试剂量下,它也显著拮抗应激引起的体重减轻和皮质酮升高。
{"title":"β-1,3-glucan Attenuated Chronic Unpredictable Mild Stress-induced Cognitive Impairment in Rodents via Normalizing Corticosterone Levels.","authors":"Saniya H Khan,&nbsp;Sheraz Khan,&nbsp;Narmeen Hashim,&nbsp;Inamullah Khan","doi":"10.2174/1871524920666200810142359","DOIUrl":"https://doi.org/10.2174/1871524920666200810142359","url":null,"abstract":"<p><strong>Background: </strong>Chronic stress elevates the cortisol beyond normal levels, which affects cognition including learning & memory. This injurious effect is primarily mediated via over excitation of metabotropic glucocorticoid receptors (mGR).</p><p><strong>Methods: </strong>The present study was aimed to appraise the neuroprotective effects of naturally occurring molecule β-1,3-glucan by interfering with stress-cortisol-mGR axis. Our data of virtual screening (in silico) exhibited the promising interactions of β-glucan with the mGR. Therefore, the study was extended to evaluate its efficacy (2.5, 5 and 10 mg/kg/ i.p) in an animal model of chronic unpredictable mild stress (CUMS, 28 days) induced memory impairment.</p><p><strong>Results: </strong>Results of the current study revealed the β-glucan provided dose dependent protection against deleterious effects of stress on learning and memory associated parameters observed in Morris water maze (MWM) task. At higher tested doses, it has also significantly antagonized the stress induced weight loss and corticosterone elevation.</p>","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"20 3","pages":"206-217"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38249454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Anti-convulsant Action and Attenuation of Oxidative Stress by Citrus limon Peel Extracts in PTZ and MES Induced Convulsion in Albino Rats. 柑桔皮提取物对PTZ和MES诱导的白化大鼠惊厥的抗惊厥作用和氧化应激的减弱。
Q3 Psychology Pub Date : 2020-01-01 DOI: 10.2174/1871524920999200831153214
Dipika R Sahu, Bimalendu Chowdhury, Biswa M Sahoo

Background: Citrus limon a small evergreen plant belongs to the family Rutaceae. These species are extensively cultivated throughout the world because of their multiple health benefits for humans and their applications in the pharmaceutical and food industries. Various studies were conducted using their plant parts (fruits, flowers, peels, leaves, blossoms) but the studies on peel extracts are very limited. However, the anticonvulsant activity of peels has not been studied yet.

Objective: The main goal of this study is to appraise the anticonvulsant effect stimulated by the antioxidant property of hydroalcoholic extracts of Citrus limon (HAECL) peels in various animal models.

Methods: The anticonvulsant and in vivo antioxidant activity of HAECL peels was observed by Maximal electric shock (MES) model, pentylenetetrazole (PTZ) induced clonic convulsion model and PTZ induced kindling test. The extract was administered to test groups at doses of 200, 400 and 600 mg/kg. orally in PTZ and MES methods. The highest dose of extract was given to the test grouped animals in case of a kindling test. After completion of the time period of kindling, the brains of all grouped animals were isolated and subjected to analyse oxidative stress parameters such as malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) biochemically to investigate the antioxidant profile of the plant.

Results: HAECL peels at doses of 400 and 600 mg/kg significantly (p<0.01) delayed the onset, decreased the duration of myoclonic spasm in PTZ induced seizure model and also significantly (p<0.01) decreased the duration of hind limb tonic extension (HLTE) as well as significantly (p<0.05) increased the postictal depression (PID) in MES model compared to control. In the PTZinduced kindling model, the malondialdehyde (MDA) level was elevated with a diminished level of SOD, CAT, GSH compared to the control group but pretreatment with HAECL at the highest dose reduced the MDA level and refined SOD, CAT and GSH status effectively.

Conclusion: From the above investigation, it was concluded that HAECL could produce significant anticonvulsant activity and also attenuate oxidative stress-induced during a seizure.

背景:柠檬是一种小型的常绿植物,属于芸香科。这些物种在世界各地被广泛种植,因为它们对人类的多种健康益处以及它们在制药和食品工业中的应用。利用其植物部分(果实、花、果皮、叶、花)进行了各种研究,但对果皮提取物的研究非常有限。然而,果皮的抗惊厥作用尚未得到研究。目的:本研究的主要目的是在不同动物模型上评价柠檬皮水醇提取物(HAECL)的抗氧化作用。方法:采用最大电击(MES)模型、戊四唑(PTZ)致阵挛性惊厥模型和PTZ致燃实验,观察HAECL果皮的抗惊厥和体内抗氧化活性。试验组分别以200、400、600 mg/kg的剂量给药。口服PTZ和MES方法。在引燃试验中,给予实验组动物最高剂量的提取物。点燃时间结束后,分离各组动物的大脑,生化分析氧化应激参数,如丙二醛(MDA)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽(GSH),以研究植物的抗氧化特性。结果:在400和600 mg/kg剂量下,HAECL具有显著的抗惊厥活性,并能减轻癫痫发作时的氧化应激。
{"title":"Anti-convulsant Action and Attenuation of Oxidative Stress by Citrus limon Peel Extracts in PTZ and MES Induced Convulsion in Albino Rats.","authors":"Dipika R Sahu,&nbsp;Bimalendu Chowdhury,&nbsp;Biswa M Sahoo","doi":"10.2174/1871524920999200831153214","DOIUrl":"https://doi.org/10.2174/1871524920999200831153214","url":null,"abstract":"<p><strong>Background: </strong>Citrus limon a small evergreen plant belongs to the family Rutaceae. These species are extensively cultivated throughout the world because of their multiple health benefits for humans and their applications in the pharmaceutical and food industries. Various studies were conducted using their plant parts (fruits, flowers, peels, leaves, blossoms) but the studies on peel extracts are very limited. However, the anticonvulsant activity of peels has not been studied yet.</p><p><strong>Objective: </strong>The main goal of this study is to appraise the anticonvulsant effect stimulated by the antioxidant property of hydroalcoholic extracts of Citrus limon (HAECL) peels in various animal models.</p><p><strong>Methods: </strong>The anticonvulsant and in vivo antioxidant activity of HAECL peels was observed by Maximal electric shock (MES) model, pentylenetetrazole (PTZ) induced clonic convulsion model and PTZ induced kindling test. The extract was administered to test groups at doses of 200, 400 and 600 mg/kg. orally in PTZ and MES methods. The highest dose of extract was given to the test grouped animals in case of a kindling test. After completion of the time period of kindling, the brains of all grouped animals were isolated and subjected to analyse oxidative stress parameters such as malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) biochemically to investigate the antioxidant profile of the plant.</p><p><strong>Results: </strong>HAECL peels at doses of 400 and 600 mg/kg significantly (p<0.01) delayed the onset, decreased the duration of myoclonic spasm in PTZ induced seizure model and also significantly (p<0.01) decreased the duration of hind limb tonic extension (HLTE) as well as significantly (p<0.05) increased the postictal depression (PID) in MES model compared to control. In the PTZinduced kindling model, the malondialdehyde (MDA) level was elevated with a diminished level of SOD, CAT, GSH compared to the control group but pretreatment with HAECL at the highest dose reduced the MDA level and refined SOD, CAT and GSH status effectively.</p><p><strong>Conclusion: </strong>From the above investigation, it was concluded that HAECL could produce significant anticonvulsant activity and also attenuate oxidative stress-induced during a seizure.</p>","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"20 3","pages":"177-185"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38328647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Link Between Brain Insulin Resistance and Cognitive Dysfunctions: Targeting Ca2+/cAMP Signalling. 脑胰岛素抵抗和认知功能障碍之间的联系:针对Ca2+/cAMP信号传导。
Q3 Psychology Pub Date : 2020-01-01 DOI: 10.2174/1871524920666200129121232
Leandro B Bergantin

Background: A correlation between cognitive dysfunctions and brain insulin resistance has been established by several clinical and experimental studies. Consistent data support that people diagnosed with brain insulin resistance, resulted from diabetes, have shown an increased risk of presenting cognitive dysfunctions, clinical signs of dementia and depression, then speculating a role of dysregulations related to insulin signalling in these diseases. Furthermore, it is currently discussed that Ca2+ signalling, and its dysregulations, may be a factor which could correlate with brain insulin resistance and cognitive dysfunctions.

Objective: Following this, revealing this interplay between these diseases may provide novel insights into the pathogenesis of such diseases.

Methods: Publications covering topics such as Ca2+ signalling, diabetes, depression and dementia (alone or combined) were collected by searching PubMed and EMBASE.

Results: The controlling of both neurotransmitters/hormones release and neuronal death could be achieved through modulating Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling).

Conclusion: Taking into account our previous reports on Ca2+/cAMP signalling, and considering a limited discussion in the literature on the role of Ca2+/cAMP signalling in the link between cognitive dysfunctions and brain insulin resistance, this article has comprehensively discussed the role of these signalling pathways in this link (between cognitive dysfunctions and brain insulin resistance).

背景:认知功能障碍与脑胰岛素抵抗之间的相关性已被一些临床和实验研究所证实。一致的数据支持,被诊断为由糖尿病引起的脑胰岛素抵抗的人,表现出认知功能障碍、痴呆和抑郁临床症状的风险增加,然后推测与胰岛素信号失调有关的作用在这些疾病中。此外,目前正在讨论Ca2+信号及其失调可能是与脑胰岛素抵抗和认知功能障碍相关的一个因素。目的:在此基础上,揭示这些疾病之间的相互作用可能为这些疾病的发病机制提供新的见解。方法:通过检索PubMed和EMBASE收集涵盖Ca2+信号、糖尿病、抑郁症和痴呆(单独或联合)等主题的出版物。结果:神经递质/激素释放和神经元死亡均可通过调节Ca2+和cAMP信号通路(Ca2+/cAMP signaling)来实现。结论:考虑到我们之前关于Ca2+/cAMP信号传导的报道,并考虑到文献中关于Ca2+/cAMP信号传导在认知功能障碍和脑胰岛素抵抗之间联系中的作用的有限讨论,本文全面讨论了这些信号通路在这一联系中的作用(认知功能障碍和脑胰岛素抵抗之间)。
{"title":"A Link Between Brain Insulin Resistance and Cognitive Dysfunctions: Targeting Ca2+/cAMP Signalling.","authors":"Leandro B Bergantin","doi":"10.2174/1871524920666200129121232","DOIUrl":"https://doi.org/10.2174/1871524920666200129121232","url":null,"abstract":"<p><strong>Background: </strong>A correlation between cognitive dysfunctions and brain insulin resistance has been established by several clinical and experimental studies. Consistent data support that people diagnosed with brain insulin resistance, resulted from diabetes, have shown an increased risk of presenting cognitive dysfunctions, clinical signs of dementia and depression, then speculating a role of dysregulations related to insulin signalling in these diseases. Furthermore, it is currently discussed that Ca2+ signalling, and its dysregulations, may be a factor which could correlate with brain insulin resistance and cognitive dysfunctions.</p><p><strong>Objective: </strong>Following this, revealing this interplay between these diseases may provide novel insights into the pathogenesis of such diseases.</p><p><strong>Methods: </strong>Publications covering topics such as Ca2+ signalling, diabetes, depression and dementia (alone or combined) were collected by searching PubMed and EMBASE.</p><p><strong>Results: </strong>The controlling of both neurotransmitters/hormones release and neuronal death could be achieved through modulating Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling).</p><p><strong>Conclusion: </strong>Taking into account our previous reports on Ca2+/cAMP signalling, and considering a limited discussion in the literature on the role of Ca2+/cAMP signalling in the link between cognitive dysfunctions and brain insulin resistance, this article has comprehensively discussed the role of these signalling pathways in this link (between cognitive dysfunctions and brain insulin resistance).</p>","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"20 2","pages":"103-109"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37589019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs. 苯并咪唑、咪唑噻唑和咪唑转化为更有效的中枢神经系统作用药物。
Q3 Psychology Pub Date : 2020-01-01 DOI: 10.2174/1871524919666190621160323
Saganuwan A Saganuwan

Background: Benzimidazole (albendazole), imidazothiazole (levamisole) and imidazole (euconazole) are used in chemotherapy of helminthosis and mycosis respectively, with central nervous system (CNS) side effects. But only a limited number of azole groups are used clinically in the treatment of CNS diseases, which are on increase and could not be cured permanently. Due to increased incidence of more challenging new CNS diseases, there is a need for the synthesis of more potent CNS drugs.

Methods: Hence, literature studies were carried out for the identification of common pathways for the synthesis of the three groups of compounds, their CNS properties and the possibility of modifying them to potent CNS drugs.

Results: Findings have shown that gloxal with formaldehyde in the presence of ammonia can be converted into imidazole, imidazothiazole and benzimidazole via distillation, condensation, alkylation, acylation, oxidation, cyclization, sulphation and amidation. However, agents such as phosphorus pentoxide, ethanolic potassium hydroxide, sodium hypochlorite, sodium hexafluroaluminate, aniline, calcium acetate, calcium benzoate, sodium hydroxide, aromatic aldehydes, bromoketones, alpha dicarbonyl compounds among others are used as reagents. The furan ring(s) may have a strong capability of penetrating CNS for the treatment of neurological disorders. The products from the three groups have agonistic, antagonistic, mixed agonistic and mixed antagonistic depressant and stimulant activities due to the presence of heteroatoms such as nitrogen, oxygen and sulphur. Imidazole may be the most potent with best characteristics of CNS penetrability and activity followed by imidazothiazole and benzimidazole.

Conclusion: Azole group is common to all the three classes and may be responsible for some of their CNS effects. The resultant compounds could act via all neurotransmitters, voltage and ligand-gated ion channels and may be chiral.

背景:苯并咪唑(阿苯达唑)、咪唑噻唑(左旋咪唑)和咪唑(纽康唑)分别用于蠕虫病和真菌病的化疗,具有中枢神经系统(CNS)副作用。但临床上用于治疗中枢神经系统疾病的唑类药物数量有限,这些疾病正在增加,而且无法永久治愈。由于更具挑战性的新型中枢神经系统疾病的发病率增加,需要合成更有效的中枢神经系统药物。方法:通过文献研究,确定三组化合物的共同合成途径、它们的中枢神经系统特性以及修饰成强效中枢神经系统药物的可能性。结果:研究结果表明,甲醛在氨存在下,经蒸馏、缩合、烷基化、酰化、氧化、环化、磺化和酰胺化等反应,可转化为咪唑、咪唑噻唑和苯并咪唑。然而,试剂包括五氧化二磷、乙醇氢氧化钾、次氯酸钠、六氟铝酸钠、苯胺、醋酸钙、苯甲酸钙、氢氧化钠、芳香醛、溴酮、-二羰基化合物等。呋喃环可能具有很强的穿透中枢神经系统的能力,可用于治疗神经系统疾病。由于氮、氧和硫等杂原子的存在,这三种基团的产物具有激动、拮抗、混合激动和混合拮抗的抑制和兴奋活性。咪唑的作用最强,其中枢神经系统穿透性和活性最好,其次是咪唑噻唑和苯并咪唑。结论:三种药物均具有唑组,可能与它们的部分中枢神经作用有关。合成的化合物可以通过所有神经递质、电压和配体门控离子通道起作用,并且可能是手性的。
{"title":"Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs.","authors":"Saganuwan A Saganuwan","doi":"10.2174/1871524919666190621160323","DOIUrl":"https://doi.org/10.2174/1871524919666190621160323","url":null,"abstract":"<p><strong>Background: </strong>Benzimidazole (albendazole), imidazothiazole (levamisole) and imidazole (euconazole) are used in chemotherapy of helminthosis and mycosis respectively, with central nervous system (CNS) side effects. But only a limited number of azole groups are used clinically in the treatment of CNS diseases, which are on increase and could not be cured permanently. Due to increased incidence of more challenging new CNS diseases, there is a need for the synthesis of more potent CNS drugs.</p><p><strong>Methods: </strong>Hence, literature studies were carried out for the identification of common pathways for the synthesis of the three groups of compounds, their CNS properties and the possibility of modifying them to potent CNS drugs.</p><p><strong>Results: </strong>Findings have shown that gloxal with formaldehyde in the presence of ammonia can be converted into imidazole, imidazothiazole and benzimidazole via distillation, condensation, alkylation, acylation, oxidation, cyclization, sulphation and amidation. However, agents such as phosphorus pentoxide, ethanolic potassium hydroxide, sodium hypochlorite, sodium hexafluroaluminate, aniline, calcium acetate, calcium benzoate, sodium hydroxide, aromatic aldehydes, bromoketones, alpha dicarbonyl compounds among others are used as reagents. The furan ring(s) may have a strong capability of penetrating CNS for the treatment of neurological disorders. The products from the three groups have agonistic, antagonistic, mixed agonistic and mixed antagonistic depressant and stimulant activities due to the presence of heteroatoms such as nitrogen, oxygen and sulphur. Imidazole may be the most potent with best characteristics of CNS penetrability and activity followed by imidazothiazole and benzimidazole.</p><p><strong>Conclusion: </strong>Azole group is common to all the three classes and may be responsible for some of their CNS effects. The resultant compounds could act via all neurotransmitters, voltage and ligand-gated ion channels and may be chiral.</p>","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"20 1","pages":"3-12"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871524919666190621160323","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37354385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity. 一些新型4,5二取代1,2,4 -三唑-3-硫酮抗惊厥活性的筛选。
Q3 Psychology Pub Date : 2019-12-08 DOI: 10.2174/1871524919666191209103003
K. Verma, U. Singh, J. Jain
OBJECTIVEIn the present study, we synthesized fifteen 4, 5-disubstituted 1, 2, 4-triazol-3-thione derivatives and evaluated for anticonvulsant activity with neurotoxicity determination.METHODThe synthesized compounds were characterized using FTIR, 1H-NMR and MS. The molecular docking study was also performed to study the interactions of compounds with LYS329 residue of gamma amino butyric acid aminotransferase (GABA-AT) using Autodock 4.2 software. The anticonvulsant activity was assessed by maximal electroshock (MES) test and subcutaneous pentylenetetrazol (scPTZ) tests. The neurotoxicity was assessed by rotarod ataxia test.RESULTSIn MES test, compound 5a, 8a and 9a were found active at 100 mg/kg and five compounds were found active at 300 mg/kg dose after 1 hr of administration. After 4 hr of drug administration, only two compounds 8a and 9a exhibited protection at both 100 mg/kg. In scPTZ test, three compounds 2a, 6a and 8a were active at 100 mg/kg and 7a was active at 300 mg/kg after 1 hr of test drug administration. Most of the compounds were found active in MES test with 8a and 9a being most active among all. In docking study, 2a was found to be best compound based on binding energy of -6.5 kcal/mol and estimated inhibition constant of 17.2 μM.CONCLUSIONMajority of synthesized compounds were found to be active in MES test whereas only few were found to possess anti scPTZ activity. Among all compounds, only 14a caused motor coordination impairment in rotarod ataxia test at 300 mg/kg 1 hr duration.
目的在本研究中,我们合成了15种4,5-二取代1,2,4-三唑-3-硫酮衍生物,并通过神经毒性测定评估其抗惊厥活性。方法利用红外光谱、核磁共振氢谱和质谱对合成的化合物进行了表征。利用Autodock 4.2软件对化合物与γ-氨基丁酸氨基转移酶LYS329残基的相互作用进行了分子对接研究。通过最大电击(MES)试验和皮下戊四氮(scPTZ)试验评估其抗惊厥活性。通过旋转棒共济失调试验评估神经毒性。结果在MES测试中,发现化合物5a、8a和9a在100mg/kg剂量下具有活性,并且在给药1小时后发现5种化合物在300mg/kg剂量下具有活力。给药4小时后,只有两种化合物8a和9a在100mg/kg下都表现出保护作用。在scPTZ试验中,三种化合物2a、6a和8a在试验药物给药1小时后在100mg/kg下具有活性,7a在300mg/kg下具有活性。在MES测试中发现大多数化合物具有活性,其中8a和9a的活性最高。在对接研究中,根据结合能为-6.5 kcal/mol和估计的抑制常数为17.2μM,发现2a是最好的化合物。结论大多数合成的化合物在MES测试中具有活性,而只有少数化合物具有抗scPTZ活性。在所有化合物中,只有14a在300mg/kg持续1小时的旋转棒共济失调测试中引起运动协调障碍。
{"title":"Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity.","authors":"K. Verma, U. Singh, J. Jain","doi":"10.2174/1871524919666191209103003","DOIUrl":"https://doi.org/10.2174/1871524919666191209103003","url":null,"abstract":"OBJECTIVE\u0000In the present study, we synthesized fifteen 4, 5-disubstituted 1, 2, 4-triazol-3-thione derivatives and evaluated for anticonvulsant activity with neurotoxicity determination.\u0000\u0000\u0000METHOD\u0000The synthesized compounds were characterized using FTIR, 1H-NMR and MS. The molecular docking study was also performed to study the interactions of compounds with LYS329 residue of gamma amino butyric acid aminotransferase (GABA-AT) using Autodock 4.2 software. The anticonvulsant activity was assessed by maximal electroshock (MES) test and subcutaneous pentylenetetrazol (scPTZ) tests. The neurotoxicity was assessed by rotarod ataxia test.\u0000\u0000\u0000RESULTS\u0000In MES test, compound 5a, 8a and 9a were found active at 100 mg/kg and five compounds were found active at 300 mg/kg dose after 1 hr of administration. After 4 hr of drug administration, only two compounds 8a and 9a exhibited protection at both 100 mg/kg. In scPTZ test, three compounds 2a, 6a and 8a were active at 100 mg/kg and 7a was active at 300 mg/kg after 1 hr of test drug administration. Most of the compounds were found active in MES test with 8a and 9a being most active among all. In docking study, 2a was found to be best compound based on binding energy of -6.5 kcal/mol and estimated inhibition constant of 17.2 μM.\u0000\u0000\u0000CONCLUSION\u0000Majority of synthesized compounds were found to be active in MES test whereas only few were found to possess anti scPTZ activity. Among all compounds, only 14a caused motor coordination impairment in rotarod ataxia test at 300 mg/kg 1 hr duration.","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871524919666191209103003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47537422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in Vitro Growth and TGF-beta Release of Human Glial Cell Tumors. 一种新型高选择性大麻素CB2激动剂减少人神经胶质细胞肿瘤的体外生长和tgf - β释放。
Q3 Psychology Pub Date : 2019-11-30 DOI: 10.2174/1871524919666190923154351
C. Cioni, M. Tassi, G. Marotta, C. Mugnaini, F. Corelli, P. Annunziata
BACKGROUNDCannabinoid receptors have been detected in human gliomas and cannabinoids have been proposed as novel drug candidates in the treatment of brain tumors. Aim of this study was to test the in vitro antitumor activity of COR167, a novel cannabinoid CB2-selective agonist displaying high binding affinity for human CB2 receptors, on tumor cells isolated from human glioblastoma multiforme and anaplastic astrocytoma.METHODSGlioma cell cultures were established from two glioblastoma multiforme and two anaplastic astrocytomas. Proliferation was measured in the presence or absence of COR167 with a bromodeoxyuridine (BrdU) cell proliferation ELISA assay. CB2 receptor expression was detected by western blotting. Apoptosis was assessed with phycoerythrin (PE) annexin V flow cytometry kit. TGF-beta 1 and 2 levels were analyzed in culture supernatants with commercial ELISAs.RESULTSCOR167 was found to significantly reduce the proliferation of both glioblastoma and anaplastic astrocytoma in a dose-dependent manner at lower doses than other known, less specific CB2 agonists. This activity is independent of apoptosis and is associated with significant reduction of TGF-beta 1 and 2 levels in supernatants of glioma cell cultures.CONCLUSIONSThese findings add to the role of cannabinoid CB2 receptor as a possible pharmacological target to counteract glial tumor growth and encourage further work to explore any other pharmacological effect of this novel CB2 agonist useful in the treatment of human gliomas.
大麻素受体已经在人类胶质瘤中被检测到,大麻素已被提出作为治疗脑肿瘤的新候选药物。本研究的目的是检测一种新型大麻素CB2选择性激动剂COR167对人多形性胶质母细胞瘤和间变性星形细胞瘤分离的肿瘤细胞的体外抗肿瘤活性。方法分别从2例多形性胶质母细胞瘤和2例间变性星形细胞瘤中培养胶质瘤细胞。用溴脱氧尿苷(BrdU)细胞增殖ELISA法测定存在或不存在COR167时的增殖情况。western blotting检测CB2受体表达。细胞凋亡检测采用植红蛋白(PE)膜联蛋白V流式细胞术。用商业elisa分析培养上清中tgf - β 1和tgf - β 2的水平。结果发现,与其他已知的特异性较低的CB2激动剂相比,tscor167在较低剂量下以剂量依赖的方式显著降低胶质母细胞瘤和间变性星形细胞瘤的增殖。这种活性与细胞凋亡无关,与胶质瘤细胞培养上清中tgf - β 1和tgf - β 2水平的显著降低有关。结论这些发现增加了大麻素CB2受体作为抑制神经胶质瘤生长的可能药理靶点的作用,并鼓励进一步探索这种新型CB2激动剂在治疗人类神经胶质瘤中的任何其他药理作用。
{"title":"A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in Vitro Growth and TGF-beta Release of Human Glial Cell Tumors.","authors":"C. Cioni, M. Tassi, G. Marotta, C. Mugnaini, F. Corelli, P. Annunziata","doi":"10.2174/1871524919666190923154351","DOIUrl":"https://doi.org/10.2174/1871524919666190923154351","url":null,"abstract":"BACKGROUND\u0000Cannabinoid receptors have been detected in human gliomas and cannabinoids have been proposed as novel drug candidates in the treatment of brain tumors. Aim of this study was to test the in vitro antitumor activity of COR167, a novel cannabinoid CB2-selective agonist displaying high binding affinity for human CB2 receptors, on tumor cells isolated from human glioblastoma multiforme and anaplastic astrocytoma.\u0000\u0000\u0000METHODS\u0000Glioma cell cultures were established from two glioblastoma multiforme and two anaplastic astrocytomas. Proliferation was measured in the presence or absence of COR167 with a bromodeoxyuridine (BrdU) cell proliferation ELISA assay. CB2 receptor expression was detected by western blotting. Apoptosis was assessed with phycoerythrin (PE) annexin V flow cytometry kit. TGF-beta 1 and 2 levels were analyzed in culture supernatants with commercial ELISAs.\u0000\u0000\u0000RESULTS\u0000COR167 was found to significantly reduce the proliferation of both glioblastoma and anaplastic astrocytoma in a dose-dependent manner at lower doses than other known, less specific CB2 agonists. This activity is independent of apoptosis and is associated with significant reduction of TGF-beta 1 and 2 levels in supernatants of glioma cell cultures.\u0000\u0000\u0000CONCLUSIONS\u0000These findings add to the role of cannabinoid CB2 receptor as a possible pharmacological target to counteract glial tumor growth and encourage further work to explore any other pharmacological effect of this novel CB2 agonist useful in the treatment of human gliomas.","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871524919666190923154351","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45001637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Noradrenergic Regulation of Hippocampus-Dependent Memory. 海马依赖性记忆的去甲肾上腺素能调节。
Q3 Psychology Pub Date : 2019-11-30 DOI: 10.2174/1871524919666190719163632
P. Nguyen, Steven A. Connor
Neuromodulation regulates critical functions of CNS synapses, ranging from neural circuit development to high-order cognitive processes, including learning and memory. This broad scope of action is generally mediated through alterations of the strength of synaptic transmission (i.e. synaptic plasticity). Changes in synaptic strength are widely considered to be a cellular representation of learned information. Noradrenaline is a neuromodulator that is secreted throughout the brain in response to novelty or increased arousal. Once released, noradrenaline activates metabotropic receptors, initiating intracellular signaling cascades that promote enduring changes in synaptic strength and facilitate memory storage. Here, we provide an overview of noradrenergic modulation of synaptic plasticity and memory formation within mammalian neural circuits, which has broad applicability within the neurotherapeutics community. Advances in our understanding of noradrenaline in the context of these processes may provide a foundation for refining treatment strategies for multiple brain diseases, ranging from post-traumatic stress disorder to Alzheimer's Disease.
神经调节调节中枢神经系统突触的关键功能,从神经回路发育到高阶认知过程,包括学习和记忆。这种广泛的作用范围通常是通过改变突触传递的强度(即突触可塑性)来介导的。突触强度的变化被广泛认为是学习信息的细胞表征。去甲肾上腺素是一种神经调节剂,在大脑对新奇事物或增强的兴奋做出反应时分泌。一旦释放,去甲肾上腺素激活代谢受体,启动细胞内信号级联,促进突触强度的持久变化和促进记忆储存。在这里,我们概述了哺乳动物神经回路中突触可塑性和记忆形成的去甲肾上腺素能调节,这在神经治疗界具有广泛的适用性。在这些过程的背景下,我们对去甲肾上腺素的理解的进展可能为改进多种脑部疾病的治疗策略提供基础,从创伤后应激障碍到阿尔茨海默病。
{"title":"Noradrenergic Regulation of Hippocampus-Dependent Memory.","authors":"P. Nguyen, Steven A. Connor","doi":"10.2174/1871524919666190719163632","DOIUrl":"https://doi.org/10.2174/1871524919666190719163632","url":null,"abstract":"Neuromodulation regulates critical functions of CNS synapses, ranging from neural circuit development to high-order cognitive processes, including learning and memory. This broad scope of action is generally mediated through alterations of the strength of synaptic transmission (i.e. synaptic plasticity). Changes in synaptic strength are widely considered to be a cellular representation of learned information. Noradrenaline is a neuromodulator that is secreted throughout the brain in response to novelty or increased arousal. Once released, noradrenaline activates metabotropic receptors, initiating intracellular signaling cascades that promote enduring changes in synaptic strength and facilitate memory storage. Here, we provide an overview of noradrenergic modulation of synaptic plasticity and memory formation within mammalian neural circuits, which has broad applicability within the neurotherapeutics community. Advances in our understanding of noradrenaline in the context of these processes may provide a foundation for refining treatment strategies for multiple brain diseases, ranging from post-traumatic stress disorder to Alzheimer's Disease.","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":"19 3 1","pages":"187-196"},"PeriodicalIF":0.0,"publicationDate":"2019-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871524919666190719163632","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45091720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Berberine: A plant derived alkaloid with therapeutic potential to combat Alzheimer's disease. 小檗碱:一种从植物中提取的生物碱,具有治疗阿尔茨海默病的潜力。
Q3 Psychology Pub Date : 2019-11-30 DOI: 10.2174/1871524919666190820160053
A. Singh, S. Singh, M. Nandi, G. Mishra, Anand Maurya, Arati Rai, G. K. Rai, R. Awasthi, Bhupesh Sharma, G. Kulkarni
Berberine (A protoberberine isoquinoline alkaloid) has shown promising pharmacological activities, including analgesic, anti-inflammatory, anticancer, antidiabetic, anti-hyperlipidemic, cardioprotective, memory enhancement, antidepressant, antioxidant, anti-nociceptive, antimicrobial, anti-HIV and cholesterol-lowering effects. It is used in the treatment of neurodegenerative disorder. It has strong evidence to serve as potent phytoconstituent in the treatment of various neurodegenerative disorders such as AD. It limits the extracellular amyloid plaques and intracellular neurofibrillary tangles. It also has lipid-glucose lowering ability, hence can be used as a protective agent in atherosclerosis and AD. However, more detailed investigations along with safety assessment of berberine are warranted to clarify its role in limiting various risk factors and AD-related pathologies. This review highlights the pharmacological basis to control oxidative stress, neuroinflammation and protective effect of berberine in AD, which will benefit to the biological scientists in understanding and exploring the new vistas of berberine in combating Alzheimer's disease.
小檗碱(一种原小檗碱类异喹啉生物碱)具有镇痛、抗炎、抗癌、降糖、抗高脂血症、保护心脏、增强记忆、抗抑郁、抗氧化、抗伤害、抗菌、抗艾滋病毒和降低胆固醇等药理作用。它被用于治疗神经退行性疾病。它有强有力的证据,作为有效的植物成分在治疗各种神经退行性疾病,如阿尔茨海默病。它限制了细胞外淀粉样斑块和细胞内神经原纤维缠结。它还具有降脂降糖能力,因此可以作为动脉粥样硬化和AD的保护剂。然而,需要对小檗碱进行更详细的研究和安全性评估,以明确其在限制各种风险因素和ad相关病理方面的作用。本文综述了小檗碱在阿尔茨海默病中控制氧化应激、神经炎症和保护作用的药理基础,有助于生物学家认识和探索小檗碱抗阿尔茨海默病的新前景。
{"title":"Berberine: A plant derived alkaloid with therapeutic potential to combat Alzheimer's disease.","authors":"A. Singh, S. Singh, M. Nandi, G. Mishra, Anand Maurya, Arati Rai, G. K. Rai, R. Awasthi, Bhupesh Sharma, G. Kulkarni","doi":"10.2174/1871524919666190820160053","DOIUrl":"https://doi.org/10.2174/1871524919666190820160053","url":null,"abstract":"Berberine (A protoberberine isoquinoline alkaloid) has shown promising pharmacological activities, including analgesic, anti-inflammatory, anticancer, antidiabetic, anti-hyperlipidemic, cardioprotective, memory enhancement, antidepressant, antioxidant, anti-nociceptive, antimicrobial, anti-HIV and cholesterol-lowering effects. It is used in the treatment of neurodegenerative disorder. It has strong evidence to serve as potent phytoconstituent in the treatment of various neurodegenerative disorders such as AD. It limits the extracellular amyloid plaques and intracellular neurofibrillary tangles. It also has lipid-glucose lowering ability, hence can be used as a protective agent in atherosclerosis and AD. However, more detailed investigations along with safety assessment of berberine are warranted to clarify its role in limiting various risk factors and AD-related pathologies. This review highlights the pharmacological basis to control oxidative stress, neuroinflammation and protective effect of berberine in AD, which will benefit to the biological scientists in understanding and exploring the new vistas of berberine in combating Alzheimer's disease.","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1871524919666190820160053","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43985072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 44
Meet Our Editorial Board Member 见见我们的编辑委员会成员
Q3 Psychology Pub Date : 2019-10-31 DOI: 10.2174/187152491903191031112823
F. Sesti
{"title":"Meet Our Editorial Board Member","authors":"F. Sesti","doi":"10.2174/187152491903191031112823","DOIUrl":"https://doi.org/10.2174/187152491903191031112823","url":null,"abstract":"","PeriodicalId":9799,"journal":{"name":"Central nervous system agents in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/187152491903191031112823","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48869110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Central nervous system agents in medicinal chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1